Arthur Kuan - 04 Oct 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan
Issuer symbol
CGON
Transactions as of
04 Oct 2024
Net transactions value
$0
Form type
4
Filing time
07 Oct 2024, 16:51:28 UTC
Previous filing
24 Jan 2024
Next filing
16 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Stock Option (Right to Buy) Award $0 +397,800 $0.000000 397,800 04 Oct 2024 Common Stock 397,800 $36.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.